433 related articles for article (PubMed ID: 30700329)
1. The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis.
Becker M; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Marshall MR; Sloand JA; Yao Q; Goossen K; Pieper D
Syst Rev; 2019 Jan; 8(1):35. PubMed ID: 30700329
[TBL] [Abstract][Full Text] [Related]
2. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible dialysis fluids for peritoneal dialysis.
Htay H; Johnson DW; Wiggins KJ; Badve SV; Craig JC; Strippoli GF; Cho Y
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007554. PubMed ID: 30362116
[TBL] [Abstract][Full Text] [Related]
4. Biocompatible dialysis fluids for peritoneal dialysis.
Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
[TBL] [Abstract][Full Text] [Related]
5. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.
Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GF; Wiggins KJ
Nephrol Dial Transplant; 2013 Jul; 28(7):1899-907. PubMed ID: 23493329
[TBL] [Abstract][Full Text] [Related]
6. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
Qi H; Xu C; Yan H; Ma J
Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
[TBL] [Abstract][Full Text] [Related]
7. Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry.
Rangaswamy D; Guddattu V; Webster AC; Borlace M; Boudville N; Clayton P; Badve S; Johnson DW; Sud K
Perit Dial Int; 2020 Mar; 40(2):209-219. PubMed ID: 32063201
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of automated versus continuous ambulatory peritoneal dialysis for end-stage kidney disease: protocol of a systematic review and meta-analysis.
Shi X; Du H; Zhang Z; Zhou Y
BMJ Open; 2022 Nov; 12(11):e065795. PubMed ID: 36323481
[TBL] [Abstract][Full Text] [Related]
9. Association of incident dialysis modality with mortality: a protocol for systematic review and meta-analysis of randomized controlled trials and cohort studies.
Marshall MR; Hsiao CY; Li PK; Nakayama M; Rabindranath S; Walker RC; Yu X; Palmer SC
Syst Rev; 2019 Feb; 8(1):55. PubMed ID: 30782218
[TBL] [Abstract][Full Text] [Related]
10. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
[TBL] [Abstract][Full Text] [Related]
12. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
13. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis.
Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
Nephrol Dial Transplant; 2012 May; 27(5):2044-50. PubMed ID: 21968011
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review.
Nochaiwong S; Ruengorn C; Mongkhon P; Thavorn K; Awiphan R; Noppakun K; Vongsanim S; Chongruksut W; Hutton B; Sood MM; Knoll GA;
Medicine (Baltimore); 2020 Apr; 99(17):e19767. PubMed ID: 32332616
[TBL] [Abstract][Full Text] [Related]
15. Practical considerations when prescribing icodextrin: a narrative review.
Silver SA; Harel Z; Perl J
Am J Nephrol; 2014; 39(6):515-27. PubMed ID: 24925229
[TBL] [Abstract][Full Text] [Related]
16. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
Peers E; Gokal R
Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
[TBL] [Abstract][Full Text] [Related]
17. An update on peritoneal dialysis solutions.
García-López E; Lindholm B; Davies S
Nat Rev Nephrol; 2012 Feb; 8(4):224-33. PubMed ID: 22349485
[TBL] [Abstract][Full Text] [Related]
18. Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients.
Wang IK; Li YF; Chen JH; Liang CC; Liu YL; Lin HH; Chang CT; Tsai WC; Yen TH; Huang CC
Nephrology (Carlton); 2015 Mar; 20(3):161-7. PubMed ID: 25487756
[TBL] [Abstract][Full Text] [Related]
19. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.
Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K
BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871
[TBL] [Abstract][Full Text] [Related]
20. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
